Johanna Tischer

Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Christoph Schmid, Michael Schleuning, Georg Ledderose et al. · Journal of Clinical Oncology · 2005 · 419 citations

Medicine, Oncology, Cell Therapy +15

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

Andreas Moosmann, Iris Bigalke, Johanna Tischer et al. · Blood · 2010 · 216 citations

Life Sciences, Immunology, Infectious Diseases +15

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

Annalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo et al. · Cancer · 2018 · 178 citations · Full text

Medicine, Hematology, Oncology +17

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

Thomas Köhnke, Christina Krupka, Johanna Tischer et al. · Journal of Hematology & Oncology · 2015 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

Maximilian Christopeit, Jürgen Finke, Ulrike Bacher et al. · Journal of Clinical Oncology · 2013 · 173 citations · Full text

Medicine, Hematology, Cell Therapy +15